Global Basal Cell Carcinoma Treatment Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI01253743

Publication Date:

January 29, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Basal Cell Carcinoma Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Basal cell carcinoma (BCC) is the most common type of skin cancer. It鈥檚 also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC.

Basal cell carcinoma that is superficial and doesn"t extend very far into the skin may be treated with creams or ointments. Surgical options are Electrodesiccation and curettage (ED&C), Topical Treatment, Freezing and Mohs Surgery. Drugs options, imiquimod (Aldara) and fluorouracil (Efudex, Fluoroplex, others) are used for several weeks to treat such low-risk basal cell carcinomas. Basal cell carcinoma that spreads to other areas of the body (metastasizes) may be treated with vismodegib (Erivedge) or sonidegib (Odomzo).
The classification of Basal Cell Carcinoma Treatment includes Topical Treatment, Hedgehog Pathway Inhibitor Therapy, Mohs Surgery, Other Surgeries and Other Treatments, and the proportion of Topical Treatment in 2018 is about 30.4%. Basal Cell Carcinoma Treatment is widely used in Hospitals, Specialty Clinics and other field. The most proportion of Basal Cell Carcinoma Treatment is Hospitals, and the sales proportion in 2018 is 53.2%. Market competition is intense. Roche, Sun Pharmaceuticals, Bausch Health Companies, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
The 鈥淏asal Cell Carcinoma Treatment Industry Forecast鈥� looks at past sales and reviews total world Basal Cell Carcinoma Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Basal Cell Carcinoma Treatment sales for 2025 through 2031. With Basal Cell Carcinoma Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Basal Cell Carcinoma Treatment industry.
This Insight Report provides a comprehensive analysis of the global Basal Cell Carcinoma Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Basal Cell Carcinoma Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Basal Cell Carcinoma Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Basal Cell Carcinoma Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Basal Cell Carcinoma Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Basal Cell Carcinoma Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Topical Treatment
Hedgehog Pathway Inhibitor Therapy
Mohs Surgery
Other Surgeries
Other Treatments
Segmentation by Application:
Hospitals
Specialty Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Sun Pharmaceuticals
Bausch Health Companies
Taro Pharmaceuticals
Mylan

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Basal Cell Carcinoma Treatment Market Size (2020-2031)
2.1.2 Basal Cell Carcinoma Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Basal Cell Carcinoma Treatment by Country/Region (2020, 2024 & 2031)
2.2 Basal Cell Carcinoma Treatment Segment by Type
2.2.1 Topical Treatment
2.2.2 Hedgehog Pathway Inhibitor Therapy
2.2.3 Mohs Surgery
2.2.4 Other Surgeries
2.2.5 Other Treatments
2.3 Basal Cell Carcinoma Treatment Market Size by Type
2.3.1 Basal Cell Carcinoma Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Basal Cell Carcinoma Treatment Market Size Market Share by Type (2020-2025)
2.4 Basal Cell Carcinoma Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Others
2.5 Basal Cell Carcinoma Treatment Market Size by Application
2.5.1 Basal Cell Carcinoma Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Basal Cell Carcinoma Treatment Market Size Market Share by Application (2020-2025)
3 Basal Cell Carcinoma Treatment Market Size by Player
3.1 Basal Cell Carcinoma Treatment Market Size Market Share by Player
3.1.1 Global Basal Cell Carcinoma Treatment Revenue by Player (2020-2025)
3.1.2 Global Basal Cell Carcinoma Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Basal Cell Carcinoma Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Basal Cell Carcinoma Treatment by Region
4.1 Basal Cell Carcinoma Treatment Market Size by Region (2020-2025)
4.2 Global Basal Cell Carcinoma Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Basal Cell Carcinoma Treatment Market Size Growth (2020-2025)
4.4 APAC Basal Cell Carcinoma Treatment Market Size Growth (2020-2025)
4.5 Europe Basal Cell Carcinoma Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Basal Cell Carcinoma Treatment Market Size Growth (2020-2025)
5 Americas
5.1 Americas Basal Cell Carcinoma Treatment Market Size by Country (2020-2025)
5.2 Americas Basal Cell Carcinoma Treatment Market Size by Type (2020-2025)
5.3 Americas Basal Cell Carcinoma Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Basal Cell Carcinoma Treatment Market Size by Region (2020-2025)
6.2 APAC Basal Cell Carcinoma Treatment Market Size by Type (2020-2025)
6.3 APAC Basal Cell Carcinoma Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Basal Cell Carcinoma Treatment Market Size by Country (2020-2025)
7.2 Europe Basal Cell Carcinoma Treatment Market Size by Type (2020-2025)
7.3 Europe Basal Cell Carcinoma Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Basal Cell Carcinoma Treatment by Region (2020-2025)
8.2 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Basal Cell Carcinoma Treatment Market Forecast
10.1 Global Basal Cell Carcinoma Treatment Forecast by Region (2026-2031)
10.1.1 Global Basal Cell Carcinoma Treatment Forecast by Region (2026-2031)
10.1.2 Americas Basal Cell Carcinoma Treatment Forecast
10.1.3 APAC Basal Cell Carcinoma Treatment Forecast
10.1.4 Europe Basal Cell Carcinoma Treatment Forecast
10.1.5 Middle East & Africa Basal Cell Carcinoma Treatment Forecast
10.2 Americas Basal Cell Carcinoma Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Basal Cell Carcinoma Treatment Forecast
10.2.2 Canada Market Basal Cell Carcinoma Treatment Forecast
10.2.3 Mexico Market Basal Cell Carcinoma Treatment Forecast
10.2.4 Brazil Market Basal Cell Carcinoma Treatment Forecast
10.3 APAC Basal Cell Carcinoma Treatment Forecast by Region (2026-2031)
10.3.1 China Basal Cell Carcinoma Treatment Market Forecast
10.3.2 Japan Market Basal Cell Carcinoma Treatment Forecast
10.3.3 Korea Market Basal Cell Carcinoma Treatment Forecast
10.3.4 Southeast Asia Market Basal Cell Carcinoma Treatment Forecast
10.3.5 India Market Basal Cell Carcinoma Treatment Forecast
10.3.6 Australia Market Basal Cell Carcinoma Treatment Forecast
10.4 Europe Basal Cell Carcinoma Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Basal Cell Carcinoma Treatment Forecast
10.4.2 France Market Basal Cell Carcinoma Treatment Forecast
10.4.3 UK Market Basal Cell Carcinoma Treatment Forecast
10.4.4 Italy Market Basal Cell Carcinoma Treatment Forecast
10.4.5 Russia Market Basal Cell Carcinoma Treatment Forecast
10.5 Middle East & Africa Basal Cell Carcinoma Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Basal Cell Carcinoma Treatment Forecast
10.5.2 South Africa Market Basal Cell Carcinoma Treatment Forecast
10.5.3 Israel Market Basal Cell Carcinoma Treatment Forecast
10.5.4 Turkey Market Basal Cell Carcinoma Treatment Forecast
10.6 Global Basal Cell Carcinoma Treatment Forecast by Type (2026-2031)
10.7 Global Basal Cell Carcinoma Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Basal Cell Carcinoma Treatment Forecast
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Basal Cell Carcinoma Treatment Product Offered
11.1.3 Roche Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Sun Pharmaceuticals
11.2.1 Sun Pharmaceuticals Company Information
11.2.2 Sun Pharmaceuticals Basal Cell Carcinoma Treatment Product Offered
11.2.3 Sun Pharmaceuticals Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sun Pharmaceuticals Main Business Overview
11.2.5 Sun Pharmaceuticals Latest Developments
11.3 Bausch Health Companies
11.3.1 Bausch Health Companies Company Information
11.3.2 Bausch Health Companies Basal Cell Carcinoma Treatment Product Offered
11.3.3 Bausch Health Companies Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Bausch Health Companies Main Business Overview
11.3.5 Bausch Health Companies Latest Developments
11.4 Taro Pharmaceuticals
11.4.1 Taro Pharmaceuticals Company Information
11.4.2 Taro Pharmaceuticals Basal Cell Carcinoma Treatment Product Offered
11.4.3 Taro Pharmaceuticals Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Taro Pharmaceuticals Main Business Overview
11.4.5 Taro Pharmaceuticals Latest Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Basal Cell Carcinoma Treatment Product Offered
11.5.3 Mylan Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Mylan Main Business Overview
11.5.5 Mylan Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂